» Articles » PMID: 19417615

Hypoxemia During One-lung Ventilation: Prediction, Prevention, and Treatment

Overview
Journal Anesthesiology
Specialty Anesthesiology
Date 2009 May 7
PMID 19417615
Citations 99
Authors
Affiliations
Soon will be listed here.
Abstract

When switching from two-lung to one-lung ventilation (OLV), shunt fraction increases, oxygenation is impaired, and hypoxemia may occur. Hypoxemia during OLV may be predicted from measurements of lung function, distribution of perfusion between the lungs, whether the right or the left lung is ventilated, and whether the operation will be performed in the supine or in the lateral decubitus position. Hypoxemia during OLV may be prevented by applying a ventilation strategy that avoids alveolar collapse while minimally impairing perfusion of the dependent lung. Choice of anesthesia does not influence oxygenation during clinical OLV. Hypoxemia during OLV may be treated symptomatically by increasing inspired fraction of oxygen, by ventilating, or by using continuous positive airway pressure in the nonventilated lung. Hypoxemia during OLV may be treated causally by correcting the position of the double-lumen tube, clearing the main bronchi of the ventilated lung from secretions, and improving the ventilation strategy.

Citing Articles

Remimazolam mitigates oxidative stress response in patients undergoing one-lung ventilation.

Li S, Sana S, Wang D Front Surg. 2025; 12:1456827.

PMID: 40060219 PMC: 11885262. DOI: 10.3389/fsurg.2025.1456827.


Predicting intraoperative hypoxemia in lung resection surgery: assessing the utility of oxygen reserve index measurements during one-lung ventilation before pleural opening.

Lee S, Kim J, Choi D J Clin Monit Comput. 2025; .

PMID: 40011394 DOI: 10.1007/s10877-025-01278-y.


Clinical practice of one-lung ventilation in mainland China: a nationwide questionnaire survey.

Liu H, Lin Y, Li W, Yang H, Kang W, Guo P BMC Anesthesiol. 2025; 25(1):7.

PMID: 39773104 PMC: 11706103. DOI: 10.1186/s12871-024-02879-x.


The short-term efficacy and safety of neoadjuvant Sintilimab combined with chemotherapy for resectable gastroesophageal junction adenocarcinoma.

Chen L, Zhang S, Ma H, Zhong K, Yang D, Sun J Langenbecks Arch Surg. 2024; 410(1):5.

PMID: 39666161 DOI: 10.1007/s00423-024-03576-6.


Bibliometric and knowledge map analysis of one lung ventilation.

Zhong Z, Wan Y, Lin Z, Chen J, Ye J J Thorac Dis. 2024; 16(9):6123-6139.

PMID: 39444860 PMC: 11494552. DOI: 10.21037/jtd-24-645.